The Switzerland-based firm's MosaiQ AiPlex Connective Tissue Diseases (CTDplus) assay is used to aid the diagnosis of autoimmune diseases.

Now, a new study suggests that vivid hallucinations—both during sleep and while awake—could point to an underlying autoimmune disorder. Published in the journal eClinicalMedicine, a recent study found ...

AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) microarray. The MosaiQ ...

Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe active lupus, a retrospective study shows.

A risk prediction score that uses machine learning and a patient’s genetic information may identify autoimmune conditions up ...

The US National Institutes of Health defined Mixed Connective Tissue Disease as “a rare autoimmune disorder characterized by ...

Kris Aquino revealed her "pain and struggle" amid suffering from lupus flare fever for over two weeks now, appealing to the ...

The Lupus Foundation of America describes lupus as a chronic disease that attacks the immune system, the part of the body ...

Cabaletta has been evaluating the CAR-T, called resecabtagene autoleucel or rese-cel , across six so-called RESET studies ...

Indian paediatric rheumatologists discuss early diagnosis and management of rheumatic disorders in children to prevent organ ...

Lupus Alert Day serves a vital purpose. It encourages others to learn more about lupus, share information on social media, ...